Ma D, Li X Y, Mellon J, Niederkorn J Y
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235, USA.
Invest Ophthalmol Vis Sci. 1998 Apr;39(5):744-53.
To evaluate the immunologic phenotype of hosts tolerized by oral administration of corneal alloantigens.
CB6F1 mice were tolerized by oral administration of allogeneic C3H/Hej corneal epithelial and endothelial cells before receiving heterotopic C3H/Hej corneal allografts. C3H-specific cytotoxic T-lymphocyte (CTL), delayed-type hypersensitivity (DTH), and mixed-lymphocyte responses were evaluated in orally tolerized and control mice. Cytokine profiles of Peyer's patch cells from orally tolerized mice were determined by enzyme-linked immunosorbent assay and mink lung cell culture bioassay.
Oral administration of corneal cells produced a profound inhibition of allospecific CTL, DTH, and mixed-lymphocyte responses. Conjugation with the B subunit of cholera toxin markedly increased the tolerizing activity of corneal endothelial cells, so that a single dose of cholera toxin-conjugated corneal cells inhibited alloimmune responses to the same degree as 10 doses of corneal cells unconjugated with cholera toxin. Peyer's patch cells from orally tolerized mice produced reduced quantities of interferon-gamma and interleukin-2 but produced increased amounts of transforming growth factor-beta and interleukin-10 compared with concentrations in normal control animals.
Oral administration of cholera toxin-conjugated corneal cells produces a dose-dependent inhibition of allospecific CTL, DTH, and mixed-lymphocyte responses. Orally induced inhibition of cell-mediated immune responses to corneal alloantigens is correlated with a sharp increase in the secretion of transforming growth factor-beta and interleukin-10 and a concomitant suppression of interleukin-2 and interferon-gamma. The well-recognized immunosuppressive characteristics of transforming growth factor-beta and interleukin-10 are suggestive that orally induced tolerance to corneal alloantigens is mediated by these cytokines.
评估通过口服角膜同种异体抗原来诱导耐受的宿主的免疫表型。
CB6F1小鼠在接受异位C3H/Hej角膜同种异体移植前,通过口服同种异体C3H/Hej角膜上皮细胞和内皮细胞诱导耐受。对口服诱导耐受的小鼠和对照小鼠评估C3H特异性细胞毒性T淋巴细胞(CTL)、迟发型超敏反应(DTH)和混合淋巴细胞反应。通过酶联免疫吸附测定法和貂肺细胞培养生物测定法测定口服诱导耐受小鼠派尔集合淋巴结细胞的细胞因子谱。
口服角膜细胞可显著抑制同种异体特异性CTL、DTH和混合淋巴细胞反应。与霍乱毒素B亚基结合可显著增强角膜内皮细胞的耐受诱导活性,以至于单剂量霍乱毒素结合的角膜细胞对同种异体免疫反应的抑制程度与10剂量未与霍乱毒素结合的角膜细胞相同。与正常对照动物相比,口服诱导耐受小鼠的派尔集合淋巴结细胞产生的γ干扰素和白细胞介素-2量减少,但转化生长因子-β和白细胞介素-10量增加。
口服霍乱毒素结合的角膜细胞可产生剂量依赖性的同种异体特异性CTL、DTH和混合淋巴细胞反应抑制。口服诱导的对角膜同种异体抗原的细胞介导免疫反应抑制与转化生长因子-β和白细胞介素-10分泌的急剧增加以及白细胞介素-2和γ干扰素的同时抑制相关。转化生长因子-β和白细胞介素-10公认的免疫抑制特性表明,口服诱导的对角膜同种异体抗原的耐受是由这些细胞因子介导的。